4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-19-014834
President and CEO gave up 5,343 shares (to pay taxes)
- President and CEO acquired 15,450 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Culley Brian M President and CEO | 2019-09-30 | Option exercise | +15,450 | 140,410 | D: show line 1 in the form | ||
| Culley Brian M President and CEO | 2019-09-30 | Shares withheld for taxes | −5,343 | $0.98 | $5,236 | 135,067 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Culley Brian M President and CEO | 2019-09-30 | Option exercise · Restricted Stock Units | −15,450 | 169,950 | D: show line 3 in the form |
Loading xslF345X03/ownership.xml…